Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 196,786 | 186,704 | 210,118 | 307,056 | 196,576 |
| Cost of Goods | 10,848 | 15,527 | 14,740 | 29,118 | 9,493 |
| Gross Profit | 185,938 | 171,177 | 195,378 | 277,938 | 187,083 |
| Operating Expenses | 241,296 | 211,922 | 241,571 | 272,236 | 305,740 |
| Operating Income | -54,510 | -40,218 | -45,453 | 5,820 | -118,164 |
| Interest Expense | 41,609 | 43,490 | 40,834 | 44,274 | 28,160 |
| Other Income | -1,872 | -2,025 | 1,591 | -118,597 | -20,266 |
| Pre-tax Income | -97,991 | -85,733 | -84,696 | -157,051 | -166,590 |
| Income Tax | 8,663 | 13,446 | 6,880 | -1,259 | -33,620 |
| Net Income Continuous | -106,654 | -99,179 | -91,576 | -155,792 | -132,970 |
| Net Income | $-106,654 | $-99,179 | $-91,576 | $-155,792 | $-132,970 |
| EPS Basic Total Ops | -1.39 | -1.29 | -1.20 | -2.07 | -1.76 |
| EPS Basic Continuous Ops | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 |
| EPS Diluted Total Ops | -1.39 | -1.29 | -1.20 | -2.07 | -1.76 |
| EPS Diluted Continuous Ops | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 |
| EPS Diluted Before Non-Recurring Items | -1.39 | -1.16 | -1.20 | N/A | N/A |
| EBITDA(a) | $-50,846 | $-36,033 | $6,541 | $84,713 | $-55,537 |